Advertisement
Screener

AVENUE THERAPEUTICS, INC. (ATXI) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

0.9 / 5 stars · 7/38 Roast Me

AVENUE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

AVENUE THERAPEUTICS, INC. (ATXI) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-18.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2024-03-18

  • AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
  • AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2023-12-310.00%
10-K · filed 2024-03-18
2023-09-300.00%
10-Q · filed 2023-11-13
2023-06-300.00%
10-Q · filed 2023-08-11
2022-12-310.00%
10-K · filed 2024-03-18
2022-09-300.00%
10-Q · filed 2023-11-13
2022-06-300.00%
10-Q · filed 2023-08-11